QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Predictors of survival in non-small cell lung cancer patients with pleural effusion undergoing thoracoscopy 期刊论文 THORACIC CANCER, 2019, 卷号: 10, 期号: 6, 页码: 1412-1418 作者:  Xie, Li-Xu;  Wang, Xing-Guang;  You, Wen-Jie;  Ma, Xiao-Bin;  Wang, Yong-Gang 收藏  |  浏览/下载：23/0  |  提交时间：2019/12/11 Malignant pleural effusion  non-small cell lung cancer  prognosis  thoracoscopy   Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion 期刊论文 THORACIC CANCER, 2018, 卷号: 9, 期号: 8, 页码: 950-955 作者:  Xu, Lisheng;  Wang, Benjie;  Gao, Meimei;  Zhang, Yan;  Qi, Qian 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 Erythromycin  intrapleural therapy  lobaplatin  malignant pleural  effusion  non-small cell lung cancer   Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect? 期刊论文 FRONTIERS IN IMMUNOLOGY, 2018, 卷号: 9 作者:  Chen, Dawei;  Song, Xinyu;  Wang, Haiyong;  Gao, Zhenwu;  Meng, Wenjuan 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/11 non-small-cell lung cancer (NSCLC)  radiotherapy  radio-memory effect  immunotherapy  interleukin-2 (IL-2)  malignant pleural effusion (MPE)   Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer 期刊论文 ONCOTARGETS AND THERAPY, 2018, 卷号: 11, 页码: 8421-8426 作者:  Song, Xinyu;  Chen, Dawei;  Guo, Jun;  Kong, Li;  Wang, Haiyong 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 NS-NSCLC  MPE  bevacizumab  pemetrexed   Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is more 期刊论文 FUTURE ONCOLOGY, 2018, 卷号: 14, 期号: 21, 页码: 2131-2138 作者:  Chen, Dawei;  Song, Xinyu;  Zhang, Yan;  Kong, Li;  Wang, Haiyong 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 adverse events  bevacizumab dose  intrapleural  malignant pleural  effusion  NSCLC  outcomes   Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 卷号: 8, 期号: 10, 页码: 18945-18953 作者:  Chen, Juan;  Li, Zhu;  Xu, Ning;  Zhang, Xin;  Wang, Yu 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/17 Malignant pleural effusion  medical thoracoscopy  pleurodesis  cancer   CEA, AFP, CA125, CA153 and CA199 in Malignant Pleural Effusions Predict the Cause 期刊论文 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 卷号: 15, 期号: 1, 页码: 363-368 作者:  Wang, Xin-Feng;  Wu, Yan-Hua;  Wang, Mao-Shui;  Wang, Yun-Shan 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17 Diagnosis  discrimination  malignant pleural effusion  tumor markers  unknown primary tumor   EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy 期刊论文 Oncology reports, 2012, 卷号: 27, 期号: 3, 页码: 880-890 作者:  Guo,H.;  Wan,Y.;  Tian,G.;  Liu,Q.;  Kang,Y. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/23 Clinical efficacy  EGFR mutation  Follow-up  Malignant pleural effusion  Tarceva